Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Emis Group Plc LSE:EMIS London Ordinary Share GB00B61D1Y04 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1,878.00 1,876.00 1,878.00 1,878.00 1,872.00 1,872.00 217,826 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 168.2 36.1 46.2 40.6 1,189

Emis Share Discussion Threads

Showing 751 to 771 of 775 messages
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
DateSubjectAuthorDiscuss
20/1/2023
07:49
CMA launch investigation
typo56
28/11/2022
14:38
why on earth i soc generale adding to this
ali47fish
14/11/2022
08:33
Unloaded mine for 1886. It has effectively become a bond paying 2% in a few months.
wad collector
09/11/2022
08:34
50p per share or 50/1875 as a fraction, or 2.666%. That's what we will lose by holding on for deal completion rather than selling now.
wad collector
08/11/2022
22:12
yes not just 50p its 50 p per share?
ali47fish
08/11/2022
21:18
The agreed price is 1925p, and closing price yesterday was around 1875p , hence a 50p reward for hanging on until completion.
wad collector
07/11/2022
18:37
but the current price is much lower- where do you get this only 50p- iam not good with maths so please explain
ali47fish
07/11/2022
17:42
So with the 1925p now drifting to sometime next yr ,and no prospect of a further dividend , I think it might be time to take the bird in the hand rather than hang on for another 50p or 2.5% in 2-4 months time....
wad collector
06/11/2022
21:57
Slippage in the timetable;

Listed healthcare software developer EMIS Group, whose products are used across a number of major UK healthcare settings, has said it now expects its £1.24bn takeover to complete early next year.

EMIS Group was established in North Yorkshire in 1987 and specialises in connected healthcare software and systems. Its products are used in primary care, community care, accident and emergency, and community and hospital pharmacies.

The Leeds-based company employs about 1,400 staff, primarily in the UK (1,150) and India (250), and it reported revenues of approximately £168m in 2021.

It was announced in June that Bordeaux UK Holdings II (Bidco), an affiliate of Optum Health Solutions (UK) (Optum UK) and a wholly owned subsidiary of UnitedHealth Group Incorporated (UnitedHealth Group) had reached an agreement with the board of EMIS Group on the terms and conditions of a recommended all cash offer.

The proposed acquisition values the entire issued, and to be issued, ordinary share capital of EMIS at approximately £1.24bn.

In August, EMIS Group shareholders voted to proceed with the takeover, and the secretary of state confirmed that no further action will be taken in relation to the acquisition.

The group has now provided an update to the timetable for completion of the deal.

It said the parties are currently in the process of finalising a Merger Notice with the Competition and Markets Authority (CMA), preliminary to a Phase One investigation of the Acquisition.

As a result, unless the relevant condition is waived by Bidco, EMIS now expects the takeover scheme to become effective in the first quarter of 2023.

Travers Smith is acting as legal adviser to EMIS, with Numis as financial adviser, corporate broker and nominated adviser, and MHP as PR adviser.

Slaughter and May is acting as legal adviser to UnitedHealth Group and Bidco, with Robey Warshaw as financial adviser and FGS Global as PR adviser.

wad collector
26/10/2022
13:17
Thats an interesting perspective. Yes I would probably have reinvested too early as well. The AIM sector has dropped much more than the FTSE100 or 350.
wad collector
19/10/2022
15:45
personally rather welcome the delay, as any money received would have been reinvested in IHT qualifying stock which would likely have lost value these last few months. Can receive the dividend in early November.
c3479z
19/10/2022
13:33
It has become a bit like a Bond, to be redeemed at a vague date. I was expecting to see a gradual closure of the gap, but thrown into that mix is the loss of the opportunity to invest elsewhere in a market that is rather different to when the offer was made, and the vague possibility that it might drag on for months, with the consolation of a further dividend of 21p if it stretched into March next year.
Maybe that uncertainty has pushed the price down this week, some trades today at 1850p which is a 75p gap.

wad collector
19/10/2022
11:31
'By the end of the year'- probably indicates between Christmas and New Year if all goes through?
c3479z
18/10/2022
13:23
when are we going to get paid- what a drag!
ali47fish
05/10/2022
14:59
SO xd 17.6p tomorrow; I see the share price nudging over £19 today in anticipation.
wad collector
28/9/2022
18:40
Well spotted amongst all those RNS'S .
Bit academic now, though does hint that the dividend will be paid.

wad collector
28/9/2022
09:28
#EMIS Group H122 presentation & acquisition summary.
Rev +5%
aOp Profit +12%
aEPS +14%

www.piworld.co.uk/company-videos/emis-group-emis-2022-half-year-results-presentation-september-2022/

tomps2
27/9/2022
11:35
If settled by Oct 7th no interim dividend will be paid. So potential 17p dividend on top of 1925p.
I am holding to bitter end.

wad collector
13/9/2022
12:24
Creeping towards the finish line now, nudging £19 . I shall miss this holding, though not the three bagger it is for me now!
wad collector
05/9/2022
11:21
wad
thanks for reminding of the timetable: thus, since the scheme is unlikely to be finalised before then it seems likely that we'll get the interim divi in October so the final result will be 1940p all being well,

c3479z
22/8/2022
21:36
The resolution has passed, but the timetable has not changed; the vagueness in the original document remains.
1925p before October or about 1940p with dividend if it is not complete by then.So buy today for 1875p to get about 3% in 2 or 3 months. Missing the opportunities elsewhere in that period.


The Scheme remains subject to the sanction by the Court at the Court Hearing and the satisfaction (or, where applicable, the waiver) of the other Conditions to the Scheme (as set out in the Scheme Document).

Subject to the Scheme receiving the sanction of the Court, the filing of the Court Order with the Registrar of Companies and the satisfaction of or, where applicable, the waiver of the other Conditions, the Scheme is expected to become Effective by the end of 2022.

The expected timetable of principal events for the implementation of the Scheme remains as set out on page 9 of the Scheme Document (as defined below). If any of the key dates and/or times set out in the timetable change, EMIS will give notice of this change by issuing an announcement through a Regulatory Information Service.

Prior to the Scheme becoming Effective, it is intended that applications will be made to the London Stock Exchange for the cancellation of trading of EMIS Shares on AIM. It is intended that on the Effective Date, share certificates in respect of EMIS Shares will cease to be valid and entitlements to EMIS Shares held within the CREST system will be cancelled.

wad collector
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
Your Recent History
LSE
EMIS
Emis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230205 00:43:33